Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Tairx, Inc.

Clinical trials sponsored by Tairx, Inc., explained in plain language.

TaiRx, Inc. 6580 TPEx

A Taiwanese biopharmaceutical company developing oncology and CNS drugs.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 3 Not yet finished but already full! 1

New pill shows promise for Hard-to-Treat neuroendocrine tumors

Disease control Ongoing

This phase II trial is testing an oral drug called CVM-1118 in 34 people with advanced neuroendocrine tumors that have not responded to standard treatments. The drug aims to slow tumor growth and improve disease control. Participants take the pill twice daily, with a possible dos…

Phase: PHASE2 • Sponsor: TaiRx, Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:06 UTC